PURPOSE/ OBJECTIVES: To describe techniques to overcome challenges of collaborating with multiple clinical sites and participants to enhance recruitment and retention for cancer symptom management randomized clinical trials (RCTs). DATA SOURCES: Personal experiences and publications related to recruitment and retention of sites and participants in RCTs, which were found by searching MEDLINE, CINAHL, and PsycINFO records. DATA SYNTHESIS: Techniques to overcome challenges related to multisite research, patient confidentiality guidelines, and work with an at-risk population were identified and applied successfully in an RCT designed to modify fatigue during and following adjuvant breast cancer chemotherapy. CONCLUSIONS: Successful recruitment and retention depended on the value that site personnel placed on symptom management research, identification of a designated contact person at each site, and flexibility in maintaining communication among the project director, contact individuals, and participants. IMPLICATIONS FOR NURSING: Initial and ongoing collaboration with participants and a contact person at each site, assurance of privacy of protected health information, and emotional support are critical to recruitment and retention throughout cancer symptom management RCTs.
PURPOSE/ OBJECTIVES: To describe techniques to overcome challenges of collaborating with multiple clinical sites and participants to enhance recruitment and retention for cancer symptom management randomized clinical trials (RCTs). DATA SOURCES: Personal experiences and publications related to recruitment and retention of sites and participants in RCTs, which were found by searching MEDLINE, CINAHL, and PsycINFO records. DATA SYNTHESIS: Techniques to overcome challenges related to multisite research, patient confidentiality guidelines, and work with an at-risk population were identified and applied successfully in an RCT designed to modify fatigue during and following adjuvant breast cancer chemotherapy. CONCLUSIONS: Successful recruitment and retention depended on the value that site personnel placed on symptom management research, identification of a designated contact person at each site, and flexibility in maintaining communication among the project director, contact individuals, and participants. IMPLICATIONS FOR NURSING: Initial and ongoing collaboration with participants and a contact person at each site, assurance of privacy of protected health information, and emotional support are critical to recruitment and retention throughout cancer symptom management RCTs.
Authors: Daniel Rothstein; Rachel A Kitt; Shannon M Smith; Salahadin Abdi; Mitchell P Engle; Michael P McDermott; Srinivasa N Raja; Dennis C Turk; Robert H Dworkin; Jennifer S Gewandter Journal: Reg Anesth Pain Med Date: 2017 May/Jun Impact factor: 6.288
Authors: Sue P Heiney; Swann Arp Adams; Bettina F Drake; Lisa H Bryant; Lynne Bridges; James R Hebert Journal: Clin Trials Date: 2010-06-22 Impact factor: 2.486
Authors: Andrea M Denicoff; Worta McCaskill-Stevens; Stephen S Grubbs; Suanna S Bruinooge; Robert L Comis; Peggy Devine; David M Dilts; Michelle E Duff; Jean G Ford; Steven Joffe; Lidia Schapira; Kevin P Weinfurt; Margo Michaels; Derek Raghavan; Ellen S Richmond; Robin Zon; Terrance L Albrecht; Michael A Bookman; Afshin Dowlati; Rebecca A Enos; Mona N Fouad; Marjorie Good; William J Hicks; Patrick J Loehrer; Alan P Lyss; Steven N Wolff; Debra M Wujcik; Neal J Meropol Journal: J Oncol Pract Date: 2013-10-15 Impact factor: 3.840
Authors: Laura M J Hochstenbach; Annemie M Courtens; Sandra M G Zwakhalen; Maarten van Kleef; Luc P de Witte Journal: BMC Cancer Date: 2015-05-19 Impact factor: 4.430
Authors: Anna Kearney; Anne Daykin; Alison R G Shaw; Athene J Lane; Jane M Blazeby; Mike Clarke; Paula Williamson; Carrol Gamble Journal: Trials Date: 2017-08-31 Impact factor: 2.279
Authors: Amanda Blatch-Jones; Jacqueline Nuttall; Abby Bull; Louise Worswick; Mark Mullee; Robert Peveler; Stephen Falk; Neil Tape; Jeremy Hinks; Athene J Lane; Jeremy C Wyatt; Gareth Griffiths Journal: Trials Date: 2020-04-03 Impact factor: 2.279